Form 8-K Amphastar Pharmaceutical For: Nov 12
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Amphastar Pharma (AMPH) Swings to Q3 Loss
November 12, 2014 4:54 PM ESTAmphastar Pharma (NASDAQ: AMPH) reported Q3 EPS of ($0.07), versus $0.05 reported last year. Revenue for the quarter came in at $59.71 million, versus $59.32 million reported last year.
For earnings history and earnings-related data on Amphastar Pharma (AMPH) click here.
... More


